nach oben

Breast Cancer Research

Erschienen in:

01.02.2000 | Review

Breast imaging technology: Current and future technologies for breast cancer imaging

verfasst von: James P Basilion

Erschienen in: Breast Cancer Research | Ausgabe 1/2000

Einloggen, um Zugang zu erhalten

Excerpt

Breast cancer is one of the most frequently diagnosed malignancies and the second leading cause of cancer deaths in American females [1]. Several improvements in diagnostic protocols have enhanced our ability for earlier detection of breast cancer, resulting in improvement of therapeutic outcome and an increased survival rate for breast cancer victims [2,3,4]. The importance of early detection of breast tumors therefore cannot be overemphasized. …

Goldsmith MF: Leading sites of new cancer cases and deaths - 1999 estimates [letter]. JAMA. 1999, 281: 405-CrossRef

Alexander FE, Anderson TJ, Brown HK, Forrest AP, Hepburn W, Kirkpatrick AE, Muir BB, Prescott RJ, Smith A: 14 years of follow-up from the Edinburgh randomised trial of breast cancer screening [see comments]. Lancet. 1999, 353: 1903-1908. 10.1016/S0140-6736(98)07413-3.CrossRefPubMed

Haffty BG, Lee C, Philpotts L, Horvath L, Ward B, McKhann C, Tocino I: Prognostic significance of mammographic detection in a cohort of conservatively treated breast cancer patients [see comments]. Cancer J Sci Am. 1998, 4: 35-40.PubMed

Moller P, Reis MM, Evans G, Vasen H, Haites N, Anderson E, Steel CM, Apold J, Lalloo F, Maehle L, Preece P, Gregory H, Heimdal K: Efficacy of early diagnosis and treatment in women with a family history of breast cancer. European Familial Breast Cancer Collaborative Group. Dis Markers. 1999, 15: 179-186.CrossRefPubMedPubMedCentral

Saarenmaa I, Salminen T, Geiger U, Holli K, Isola J, Karkkainen A, Pakkanen J, Piironen A, Salo A, Hakama M: The visibility of cancer on earlier mammograms in a population-based screening programme. Eur J Cancer. 1999, 35: 1118-1122. 10.1016/S0959-8049(99)00103-3.CrossRefPubMed

Patel MR, Whitman GJ: Negative mammograms in symptomatic patients with breast cancer. Acad Radiol. 1998, 5: 26-33.CrossRefPubMed

White S, Taetle R, Seligman PA, Rutherford M, Trowbridge IS: Combinations of anti-transferrin receptor monoclonal antibodies inhibit human tumor cell growth in vitro and in vivo: evidence for synergistic antiproliferative effects. Cancer Res. 1990, 50: 6295-6301.PubMed

Basar I, Ayhan A, Bircan K, Ergen A, Tasar C: Transferrin receptor activity as a marker in transitional cell carcinoma of the bladder. Br J Urol. 1991, 67: 165-168.CrossRefPubMed

Recht L, Torres CO, Smith TW, Raso V, Griffin TW: Transferrin receptor in normal and neoplastic brain tissue: implications for brain-tumor immunotherapy [see comments]. J Neurosurg. 1990, 72: 941-945.CrossRefPubMed

10.

Inoue T, Cavanaugh PG, Steck PA, Brunner N, Nicolson GL: Differences in transferrin response and numbers of transferrin receptors in rat and human mammary carcinoma lines of different metastatic potentials. J Cell Physiol. 1993, 156: 212-217.CrossRefPubMed

11.

Kresse MS, Wagner S, Pfefferer D, Lawaczeck R, Elste V, Semmler W: Targeting of ultrasmall superparamagnetic iron oxide (USPIO) particles to tumor cells in vivo by using transferrin receptor pathways. Magn Reson Med. 1998, 40: 236-242.CrossRefPubMed

12.

Moore A, Basilion JP, Chiocca EA, Weissleder R: Measuring transferrin receptor gene expression by NMR imaging. Biochim Biophys Acta. 1998, 1402: 239-249. 10.1016/S0167-4889(98)00002-0.CrossRefPubMed

13.

Weissleder R, Moore A, Mahmood U, Bhorade R, Benveniste H, Chiocca EA, Basilion JP: In vivo magnetic resonance imaging of transgene expression. Nat Med. 2000, 6: 351-355. 10.1038/73219.CrossRefPubMed

14.

St Croix B, Rago C, Velculescu V, Traverso G, Romans KE, Montgomery E, Lal A, Riggins GJ, Lengauer C, Vogelstein B, Kinzler KW: Genes expressed in human tumor endothelium. Science. 2000, 289: 1197-1202. 10.1126/science.289.5482.1197.CrossRefPubMed

15.

Weissleder R, Tung CH, Mahmood U, Bogdanov A: In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat Biotechnol. 1999, 17: 375-378. 10.1038/7933.CrossRefPubMed

16.

Louie AY, Huber MM, Ahrens ET, Rothbacher U, Moats R, Jacobs RE, Fraser SE, Meade TJ: In vivo visualization of gene expression using magnetic resonance imaging. Nat Biotechnol Markers. 2000, 18: 321-325. 10.1038/73780.CrossRef

Titel: Breast imaging technology: Current and future technologies for breast cancer imaging
verfasst von: James P Basilion
Publikationsdatum: 01.02.2000
Verlag: BioMed Central
Erschienen in: Breast Cancer Research / Ausgabe 1/2000
Elektronische ISSN: 1465-542X
DOI: https://doi.org/10.1186/bcr264

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

Breast imaging technology: Current and future technologies for breast cancer imaging

Excerpt

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2000

Phase III trial of chemotherapy ? HerceptinR in metastatic breast cancer

Normal mammary epithelial cells escape of senescence

Iressa inhibits growth of HER-2-overexpressing cells

Her-2/neu and topoisomerase IIaexpression in primary and metastatic breast cancer

Pathologic features associated with nonsentinel lymph node metastasis

Comparison of written reports of mammography, sonography and magnetic resonance mammography for preoperative evaluation of breast lesions, with special emphasis on magnetic resonance mammography

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie